01-08-2013 | PHASE I STUDIES
A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors
Published in: Investigational New Drugs | Issue 4/2013
Login to get access01-08-2013 | PHASE I STUDIES
Published in: Investigational New Drugs | Issue 4/2013
Login to get access